[EN] NOVEL CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE<br/>[FR] NOUVELLE FORME CRISTALLINE DE BROMHYDRATE DE VORTIOXÉTINE
申请人:SANDOZ AG
公开号:WO2014044721A1
公开(公告)日:2014-03-27
The present invention is directed to a crystalline compound comprising a hydrobromide acid (HBr) salt of a compound of formula (I) (1-2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine, INN: vortioxetine), having an XRPD pattern with characteristic peaks (expressed in 2θ ± 0,2° 2θ (CuKα radiation)) at 5.5°, 14.8°, 16.7° and 20.0° and processes for obtaining the same.